GL検索 v0.1.0
画像は 208 ページを描画したものです
page 208

p.208 抽出テキスト

9)  Lee CAA, Seo HS, Armien AG, et al: Modeling and rescue of defective blood-

brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients. Fluids Barriers CNS 2018; 15: 9. 10)  Zierfuss B, Weinhofer I, Kühl JS, et al. Vorinostat in the acute neuroinflammatory

form of X-linked adrenoleukodystrophy. Ann Clin Transl Neurol 2020; 7: 639-652. 11)  Gupta AO, Furcich JW, Nascene DR, et al: Targeting VEGF-mediated blood-brain

barrier disruption in advanced cerebral leukodystrophy. J Neuroimmunol. 2024; 393:

578395 12)  Rodríguez-Pascau L, Vilalta A, Cerrada M, et al: The brain penetrant PPARγ

agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy. Sci Transl Med 2021; 13: eabc0555. 13)  Golse M, Weinhofer I, Blanco B, et al: Leriglitazone halts disease progression in

adult patients with early cerebral adrenoleukodystrophy. Brain 2024; 147: 3344-

3351 14)  Chataway J, Wade C, Murphy E, et al: An alternative therapeutic approach to

haematopoetic stem cell transplantation in early cerebral adrenoleukodystrophy. Brain 2024; 147: 3271-3273. 15)  Jaspers YRJ, Yska HAF, Bergner CG, et al: Lipidomic biomarkers in plasma

correlate with disease severity in adrenoleukodystrophy. Commun Med (Lond)2024; 4: 175. 16)  Kettwig M, Klemp H, Nessler S, et al: Targeted metabolomics revealed changes in

phospholipids during the development of neuroinflammation in Abcd1 tm1Kds mice and X-linked adrenoleukodystrophy patients. J Inherit Metab Dis 2021; 44: 1174-1185. 17)  Weinhofer I, Rommer P, Zierfuss B, et al: Neurofilament light chain as a potential

biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nat Commun 2021; 12: 1816. 18)  Wang H, Davison MD, Kramer ML, et al: Evaluation of neurofilament light chain

as a biomarker of neurodegeneration in X-Linked childhood cerebral adrenoleukodystrophy. Cells. 2022; 11: 913. 19)  Weinhofer I, Rommer P, Gleiss A, et al: Biomarker-based risk prediction for the

onset of neuroinflammation in X-linked adrenoleukodystrophy. EBioMedicine. 2023; 96: 104781.